Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs

Author： Ozaki K.   Sudo H.   Muramatsu H.   Yogo K.   Kamei K.   Koga H.   Itoh Z.   Ōmura S.   Takanashi H.  

Publisher： Springer Publishing Company

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.15, Iss.1, 2007-02, pp. : 36-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of a selective 5-HT 3 receptor agonist on gastric motility in fasted and fed dogs

By Nagakura Y.   Ito H.   Kamato T.   Nishida A.   Miyata K.  

European Journal of Pharmacology, Vol. 327, Iss. 2, 1997-05 ,pp. : 189-193

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM348, a novel, potent and orally active 5-HT 2C receptor agonist

By Kimura Y.   Hatanaka K.-i.   Naitou Y.   Maeno K.   Shimada I.   Koakutsu A.   Wanibuchi F.   Yamaguchi T.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 37-43

Elsevier

Access to resources Recommend Favorite

EM574, an erythromycin derivative, is a motilin receptor agonist in the rabbit

By Sato F.   Sekiguchi M.   Marui S.   Inatomi N.   Shino A.   Itoh Z.   Omura S.  

European Journal of Pharmacology, Vol. 322, Iss. 1, 1997-03 ,pp. : 63-71

Elsevier

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Paranjape S.B.   Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 825-834

Informa Healthcare

Access to resources Recommend Favorite